Beryl Drugs Ltd — Important, 13-04-2026: Company Update
13-04-2026 | 05:11 pm
13-04-2026 | 05:11 pm
Beryl Drugs Limited qualifies for exemptions from certain corporate governance and secretarial compliance rules. The company's paid-up capital stands at Rs. 5.07 Cr and its net worth was Rs. 9.50 Cr as per the previous financial year's audited results. These figures are below the thresholds set for such compliances. Consequently, the company is not obligated to submit an Annual Secretarial Compliance report for the financial year 2025-2026. This exemption streamlines operational compliance and reduces administrative burden for the company.
No comments yet. Be the first to comment!
